Novo Nordisk Pharma (Taiwan) Ltd.
Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat diabetes and other serious chronic diseases such as obesity and rare blood and endocrine disorders. We do so by pioneering scientific breakthroughs, expanding access to our medicines, and working to prevent and ultimately cure disease.
Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat diabetes and other serious chronic diseases such as obesity and rare blood and endocrine disorders. We do so by pioneering scientific breakthroughs, expanding access to our medicines, and working to prevent and ultimately cure disease.
Healthcare Asia Pharma Awards 2023 Winner: Novo Nordisk Pharma (Taiwan) Ltd.
Healthcare Asia Pharma Awards 2023 Winner: Novo Nordisk Pharma (Taiwan) Ltd.
Novo Nordisk Pharma (Taiwan) Ltd. wins the ESG Programme of the Year - Taiwan award at the Healthcare Asia Pharma Awards 2023.
Novo Nordisk Pharma Taiwan awarded ESG Program of the Year - Taiwan by the Healthcare Asia Pharma Awards
The company's Corporate Social Responsibility awareness programme aims to give back to local communities and take action for environmental improvement.
Most Read
1. The Medical City brings home five wins at Healthcare Asia Awards 2025 2. Gleneagles HK to advance health solutions through new partnerships 3. IHH Healthcare to fast-track shift to value-based care 4. China’s biopharma sector strikes $30b in oncology licensing deals 5. SingHealth, Philips to roll out smart ICUs to cut false alarmsResource Center
Read Here
Advertise
Sign Up
Partner Events
Event News
It was recognised for its success in delivering world-class specialised services that rival the best healthcare institutions globally.
Commentary
Strategic brand & design: A smart prescription to drive growth in healthcare